Filing Details
- Accession Number:
- 0001203311-14-000049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-12 20:33:19
- Reporting Period:
- 2014-06-10
- Filing Date:
- 2014-06-12
- Accepted Time:
- 2014-06-12 20:33:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-01-10 | 5,000 | $0.00 | 1,038,554 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2014-05-14 | 325,479 | $0.00 | 525,217 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2014-06-10 | 11,200 | $5.92 | 536,417 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-10 | 11,200 | $40.14 | 525,217 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-06-10 | 11,200 | $0.00 | 11,200 | $5.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 33,604 | 2015-01-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 100,000 | Indirect | by Trust |
Footnotes
- The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan.
- Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
- Amount of Securities beneficially owned following reported transactions includes 189,250 Restricted Stock Units subject to vesting.
- Shares vested at a rate of 25% on 1/31/06 and monthly thereafter until all the shares were fully vested on 1/31/09.
Billionaire Hedge Funds
